Masimo Gains FDA Clearance for Continuous Oxygen Delivery Monitoring
IRVINE, Calif., August 25, 2026 Masimo, a Danaher company focused on specialty diagnostics and patient monitoring technologies, announced that...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
IRVINE, Calif., August 25, 2026 Masimo, a Danaher company focused on specialty diagnostics and patient monitoring technologies, announced that...
Aurora, Colorado, August 3, 2026 A University of Colorado Anschutz Medical Campus-led multicenter clinical trial has demonstrated that an...
